Kimberly-Clark put the words “Germ Removal” on the front of a product that contains zero germ-killing ingredients — and when consumers tried to hold the company accountable in court, their own lawyers’ paperwork errors handed Kimberly-Clark a free escape route.

The Wipe That Doesn’t Do What It Says

The product at the center of this case is Kleenex Germ Removal Wet Wipes. The front label tells shoppers the wipes “safely wipes away 99% of germs from skin” with “no harsh chemicals.” A banner on the same label shouts “WIPES AWAY” in all capital letters — which, in retrospect, was a very precise disclosure that nobody was meant to read closely.

The back label lists the ingredients. According to the court record, those ingredients include soaps. They include zero germicides. A germicide is a substance that kills germs; soap does not kill germs. Soap loosens them from surfaces so they can be rinsed or wiped away. The distinction is scientifically meaningful, practically important, and commercially convenient for a company charging a premium for a product marketed as a hygiene solution.

Three consumers — Judah Rosenwald, Cindy Rutter, and Craig Chouraki-Lewin — filed a class action lawsuit in August 2022, arguing that the labeling misled them into believing the wipes would kill germs rather than merely wipe them away. They brought California consumer protection claims on behalf of themselves and every similarly deceived buyer. What happened next has less to do with whether Kimberly-Clark deceived people and more to do with the labyrinthine procedural rules that determine whether a federal court can even hear the complaint.

Three Complaints, Zero Jurisdiction: The Legal Malpractice That Saved a Corporation

To sue in federal court using “diversity jurisdiction,” a plaintiff’s complaint must do two basic things: tell the court that the parties are from different states, and tell the court that the amount of money at stake clears the legal threshold. These are not obscure technicalities. They are foundational requirements that every first-year law student learns.

The plaintiffs’ lawyers filed an original Complaint, then a First Amended Complaint, then a Second Amended Complaint. Not one of those three documents properly stated Kimberly-Clark’s citizenship. The Second Amended Complaint (SAC) also stated zero dollar amount for the controversy. According to the Ninth Circuit’s opinion, the SAC “says nothing about Kimberly-Clark’s citizenship” and “states no dollar value for the amount in controversy, either in the jurisdictional allegations or elsewhere.”

The district court had already dismissed earlier versions for other reasons. The Ninth Circuit, reviewing the appeal, flagged the jurisdiction problem on its own initiative and gave the plaintiffs one more chance to fix it — a proposed Third Amended Complaint (TAC). They fixed the citizenship problem. They could not fix the money problem. The case was over.

The Price Tag That Didn’t Make It Into the Settlement: What Consumers Actually Lost

There is no settlement in this story. There is no fine. There is no Kimberly-Clark executive standing before a camera saying “we take this seriously.” What there is: a dismissal, a corporation that walked away without answering a single question on the merits, and millions of shoppers who reached for a product called “Germ Removal” during years when germ removal felt like it could mean the difference between life and serious illness.

The lawsuit was filed in August 2022. That is not an arbitrary date. The world was still deep in a public health hangover. Masks were coming off, but anxiety about germs, surfaces, and transmission had been baked into daily life for over two years. When a parent standing in a CVS or Walgreens sees a product that says “Germ Removal” on the front and “wipes away 99% of germs” on the label, they are not just buying a convenience product. They are buying reassurance. They are buying the feeling that they can protect their family. Kimberly-Clark sold that feeling. The ingredients did not back it up.

The court record notes that the wipes are sold “throughout the US” at drug stores like Walgreens, CVS, and Rite Aid, online through Amazon, and through chains like Stop & Shop. That is saturating distribution. The court calculated at least 425,000 units sold nationwide during the statutory period — and that figure assumes every package sold for the highest listed price of $14.03 ($14.03 — the cost of a fast food combo meal, the kind of impulse purchase that adds up to real money for working families). In reality, many packages sold for $0.99 or $2.99, meaning the number of individual purchase transactions was “many times larger.” Multiply that volume by the trust embedded in a Kleenex brand name and the post-pandemic context of the purchase, and the scale of what consumers were misled about becomes clear.

What the court’s math also reveals, almost accidentally, is how the legal system itself becomes a shield for corporations. The per-unit harm here was small in dollar terms — somewhere between $0.99 and $14.03 per person. No single buyer lost their life savings. That is precisely how modern consumer fraud often operates: the harm per victim is small enough to make individual lawsuits economically irrational, but the aggregate harm across hundreds of thousands of buyers is enormous. Class actions exist specifically to aggregate these small harms into a case worth filing. When procedural errors collapse a class action before it reaches the merits, the corporation keeps the revenue, nobody gets a refund, the misleading label may stay on shelves, and the legal system registers the whole episode as a non-event. The consumers absorbed a loss. Kimberly-Clark absorbed nothing.

Straight From the Court Record: The Damning Quotes

“The front label says that the wipes are for ‘germ removal’ and that the product ‘safely wipes away 99% of germs from skin’ with ‘no harsh chemicals.’ Next to the last two statements, the front label has a banner that says ‘WIPES AWAY’ in all capital letters. The back label also provides a list of ingredients; it indicates that the product contains soaps but no germicides.” — Ninth Circuit Opinion, Rosenwald v. Kimberly-Clark Corp., Filed September 24, 2025. Core factual finding describing the product’s labeling and ingredient contradiction.

“The TAC says nothing to suggest any class member bought enough wipes to bring their actual damages near $1,000.” — Ninth Circuit Opinion. The court’s definitive finding that individual consumer harm was too small to reach the $75,000 jurisdictional threshold — even after multiple amended complaints.

“Even if we hacked the class down to as few as 1,000 members, which stretches the bounds of generosity, Rosenwald would need $64 million in fees. We can say, to a legal certainty, that is not going to happen.” — Ninth Circuit Opinion. The court’s calculation showing that attorney’s fees, even under wildly generous assumptions, could never bridge the gap to the jurisdictional threshold. $64 million — enough to provide a year of free groceries to over 35,000 families.

“Plaintiffs are not pro se; they have sophisticated counsel. Even so, they failed to plead subject-matter jurisdiction in the original Complaint, First Amended Complaint, or SAC. We issued two orders outlining our jurisdictional concerns. Yet Plaintiffs’ TAC is far from alleging a viable amount in controversy.” — Ninth Circuit Opinion. The court’s direct indictment of plaintiff counsel’s repeated failure to meet basic pleading requirements, even after explicit judicial warnings.

“To get $64,000 in fees per class member, Rosenwald needs $3.4 billion in total fees. He has no chance of nearing that figure.” — Ninth Circuit Opinion. The court’s calculation of the total attorney’s fees required to clear the jurisdictional bar across an estimated 53,500 California class members. $3.4 billion — more than the entire annual budget of some U.S. states’ public health departments.

Who Gets Hurt When Germ Removal Means Nothing

Public Health: Selling Safety Theater in a Post-Pandemic Market

The core allegation in this case is that Kimberly-Clark labeled a soap-based wipe as a germ-removal product, leading consumers to believe it functioned as a germicide. The distinction between “wipes away germs” and “kills germs” is not semantic hair-splitting. It is a clinically significant difference that shapes how people make health decisions. A parent who believes a wipe kills germs on a child’s hands before lunch is making a different hygiene calculation than one who knows they are using glorified soap on a damp cloth.

The product sold in drug stores like Walgreens, CVS, and Rite Aid — outlets where consumers already associate the environment with health and medical trust. The Kleenex brand carries decades of association with illness management and hygiene. Kimberly-Clark leveraged that brand equity to push a product that, according to the lawsuit’s allegations, did not live up to its marketed function. The court never ruled on whether those allegations were true on the merits — the case was dismissed on procedural grounds before any evidence was weighed.

What makes this a public health concern rather than a mere commercial dispute is scale and timing. The court estimated at minimum 53,500 units sold in California alone, and “many times larger” volumes given the low price points of $0.99 and $2.99 per package. With distribution through Amazon and national pharmacy chains, the product reached consumers nationally who may have substituted it for products that actually disinfect, particularly during a period of heightened germ anxiety. No regulatory body appears in the record as having investigated or sanctioned Kimberly-Clark for the labeling at issue.

Economic Inequality: How Cheap Products and Broken Courts Hit the Same People Twice

The per-unit cost of these wipes ranged from $0.99 to $14.03. That price range tells a story about who buys them. Budget-conscious consumers — the ones buying the $0.99 pack at a discount pharmacy — are the ones least able to absorb the financial and health cost of a product that does not do what the label says. They are also the least equipped to hire an attorney and sue a Fortune 500 corporation.

The class action mechanism exists precisely because aggregating small, individually non-actionable harms is the only way working people can access the legal system against large corporations. When a class action collapses due to attorney error before it ever reaches the merits, the people who absorb that failure are the consumers — not the lawyers who will move on to the next case, and certainly not Kimberly-Clark. The court noted that the plaintiffs had “sophisticated counsel” and still failed to plead jurisdiction correctly across four attempts. That is a failure of the professionals who were supposed to be the working-class consumer’s only lever against a billion-dollar corporation.

Kimberly-Clark earned $6 million ($6 million — enough to give every California class member an estimated $112 refund) from this product during the statutory period. Every dollar of that revenue was earned, at least in part, from the brand promise embedded in the label. The consumers who funded that revenue get nothing from this litigation. The corporation absorbs no consequence. The asymmetry is not an accident; it is the architecture.

What $6 Million in Wipe Sales Bought Kimberly-Clark

The Case Isn’t Dead. Here’s What to Watch.

The dismissal is WITHOUT PREJUDICE. That means the plaintiffs can refile in California state court — and if they do, Kimberly-Clark cannot guarantee a removal back to federal court. State court is where this case may actually be heard on its merits. Watch for a refiling.

Corporate Roles to Watch

• Kimberly-Clark Corporation — Product Marketing and Labeling Division
• Kimberly-Clark Corporation — Legal and Regulatory Compliance Department
• Kimberly-Clark Corporation — Consumer Products Division (Kleenex Brand)

Regulatory Watchlist

• Federal Trade Commission (FTC) — deceptive advertising and labeling enforcement
• Food and Drug Administration (FDA) — over-the-counter product claims and germicide/antiseptic labeling rules
• California Department of Consumer Affairs — state-level consumer protection enforcement
• California Attorney General’s Office — authority to bring consumer protection actions without the jurisdictional obstacles that sank this private lawsuit
• Consumer Financial Protection Bureau (CFPB) — broader consumer deception monitoring

What You Can Do Right Now

File a complaint with the FTC at ReportFraud.ftc.gov. If you purchased Kleenex Germ Removal Wet Wipes believing they killed germs, your complaint becomes part of the federal record and can trigger investigations that private lawsuits cannot. The FTC does not have the same jurisdictional minimums that killed this case.

Contact the California Attorney General’s consumer protection hotline. State attorneys general have standing to bring cases that individual consumers cannot, and they are not bound by the $75,000-per-person federal bar. A pattern of complaints is how enforcement priorities get set.

At the community level, share product labels. Photograph the front and back of any consumer product that makes health or safety claims and compare what the label promises to what the ingredient list delivers. Local mutual aid networks and consumer advocacy groups — not just lawyers — are the front line of accountability when the courts turn people away. Organized people hold more power than isolated consumers with $14 worth of grievance and no attorney.